An innovative decision-support system for improved care pathways for patients with neurodegenerative diseases and comorbidities
This program, part of the Horizon Europe framework under the Innovative Health Initiative Joint Undertaking (IHI JU), sought to develop an innovative decision-support system. The core objective was to enhance care pathways for patients with neurodegenerative diseases and comorbidities by integrating diverse health data and fostering cross-sectoral collaboration.
Who is Funded and Program Objectives
This section details the target beneficiaries, geographical reach, and overarching goals of the funding program, emphasizing a collaborative and patient-centric approach to healthcare innovation.
What is Funded
This section outlines the types of projects and thematic areas supported by the program, focusing on digital health solutions for neurodegenerative diseases, and clarifies general cost eligibility.
Type and Scope of Funding
This section specifies the nature of financial support provided, including the type of funding instrument, the maximum funding available per project, and co-financing requirements.
Conditions and Requirements for Applicants
This section details the key conditions and requirements applicants must meet, covering application terms, consortium rules, and crucial provisions related to data and intellectual property.
Application Procedure
This section outlines the procedural steps for submitting proposals and how applications are evaluated and decisions are communicated.
Legal Basis and Governing Framework
This section defines the legal and foundational documents that govern the funding program, providing clarity on its authorization and operational framework.
Similar Programs
Funding Overview
Funding Status:
Closed
Maximum Amount:
7,000,000 €
Allocated Budget:
5,000,000 € - 7,000,000 € per proposal
Award Channel:
Framework Programme Call
Region:
European Union
Sectors:
Healthcare, Medical Technology, Research and Development, Software Development, Information and Communication Technology
Beneficiaries:
Patients with neurodegenerative diseases and comorbidities
Application Type:
Consortium Required
Funding Stages:
Applied Research, Experimental Development, Prototyping, Pilot Testing, Product Development, Process Optimization
Funding Provider
Program Level:
European Union
Funding Body:
European Union
Managed By:
Innovative Health Initiative Joint Undertaking (IHI JU)
Additional Partners:
Leading healthcare industry associations (COCIR, EFPIA, EuropaBio, MedTech Europe)
Website: